
Baroda BNP Paribas Asset Management has launched a new mutual fund scheme that lets retail investors participate in India’s biggest business groups like Tata, Birla, and Ambani companies — starting at just Rs 500 per month through SIP.
Subscription Window: september 2, 2025 – september 15, 2025
Key Highlights
What Makes It Unique?
Diversified Exposure: Invests in stocks from at least 4 major conglomerates.
Balanced Risk: No more than 25% exposure to any single group.
Benchmark: Tracks the BSE Select business Groups Index.
Managed by Experts: Fund managers Jitendra sriram and Kushant Arora.
Why Consider This Fund?
Diversified Revenue Streams – Conglomerates work across industries like finance, IT, manufacturing, and FMCG.
Strong Brand Trust – Groups with decades of legacy and credibility.
Financial Strength – Easier access to funding for expansion.
Value Unlocking – corporate actions like demergers & restructuring can create fresh opportunities.
Who Should Invest?
Investors who want exposure to India’s largest growth stories.
Those who prefer professional management instead of stock-picking.
Small investors looking for long-term growth with a low entry barrier (Rs 500 SIP).
Expert Speak
Sanjay Chawla, CIO – Equity: “This fund allows investors to be part of multi-generational companies, offering stability and long-term growth.”
Jitendra sriram, Fund Manager: “Restructuring and demergers in large business groups are unlocking significant value.”
Final Takeaway
The Baroda BNP Paribas business Conglomerates Fund opens doors for everyday investors to join India’s biggest business houses. With a low entry cost, diversified exposure, and expert management, this scheme could be a smart addition to long-term portfolios.
Deadline: Open until September 15, 2025.
Disclaimer:
The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of any agency, organization, employer, or company. All information provided is for general informational purposes only. While every effort has been made to ensure accuracy, we make no representations or warranties of any kind, express or implied, about the completeness, reliability, or suitability of the information contained herein. Readers are advised to verify facts and seek professional advice where necessary. Any reliance placed on such information is strictly at the reader’s own risk.